← All stocks

BioAtla, Inc.

BCAB No buying or selling
CIK 0001826892 #5430 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
WALDRON RICHARD A
Former Chief Financial Officer
343,421
$800.17K
+30.0%
Smith Scott Andrew
Director
321,550
$749.21K
+7.9%
SHORT JAY M PHD
Chief Executive Officer
84,300
$196.42K
STEINMAN LAWRENCE
Director
78,459
$182.81K
+42.8%
GRAY MARY ANN
Director
77,397
$180.34K
+43.6%
Williams Eddie
Director
60,200
$140.27K
+64.0%
MCBRINN SYLVIA
Director
59,125
$137.76K
+66.0%
Moran Susan
Director
52,307
$121.88K
+81.6%
Sievers Eric
Chief Medical Officer
11,346
$26.44K
Vasquez Christian
Chief Financial Officer
10,476
$24.41K

No percentages here. This company's share count has moved by a factor of 46.3 over the window, from 1,269,286 to 58,792,088 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 940,525
History held since 17 Dec 2020